Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Newly developed gene therapy helps decelerate aging process

Newly developed gene therapy helps decelerate aging process

Researchers develop new computer game for dementia carers

Researchers develop new computer game for dementia carers

UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s

UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s

New therapeutic molecules show promise in reversing memory loss related to depression, aging

New therapeutic molecules show promise in reversing memory loss related to depression, aging

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

Study finds no association between antiepileptic drug use and dementia risk

Study finds no association between antiepileptic drug use and dementia risk

Millions of British people breathe toxic air travelling to GPs

Millions of British people breathe toxic air travelling to GPs

Lactate activates multiple genes that modulate neuronal activity

Lactate activates multiple genes that modulate neuronal activity

Machine learning algorithm could accelerate the search for new drugs

Machine learning algorithm could accelerate the search for new drugs

Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s

Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s

FDA issues warning letters to companies for selling unapproved products that claim to treat Alzheimer’s

FDA issues warning letters to companies for selling unapproved products that claim to treat Alzheimer’s

Alzheimer's disease protection from exercise hormone irisin

Alzheimer's disease protection from exercise hormone irisin

Study reveals how exercise may protect against Alzheimer's disease

Study reveals how exercise may protect against Alzheimer's disease

Blood cells could hold the key to aging

Blood cells could hold the key to aging

Simple drug cocktail converts neighboring glial cells into functional new neurons

Simple drug cocktail converts neighboring glial cells into functional new neurons

RNAs are involved in protein aggregation and neurodegenerative diseases, research reveals

RNAs are involved in protein aggregation and neurodegenerative diseases, research reveals

New study aims to investigate lifestyle effects on cognitive function in older adults

New study aims to investigate lifestyle effects on cognitive function in older adults

Professional musicians are not protected from brain-related diseases

Professional musicians are not protected from brain-related diseases

Blood-clotting factor may cause Alzheimer's disease

Blood-clotting factor may cause Alzheimer's disease

Hibernation spurts of hamsters hold clues to better treatments for Alzheimer's disease

Hibernation spurts of hamsters hold clues to better treatments for Alzheimer's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.